Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 212 to 261 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylate cyclase, type vi (ec 4.6.1.1) (atp pyrophosphate-lyase) (ca(2+)-inhibitable adenylyl cyclase). [source:swissprot;acc:o43306]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
400\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylate kinase isoenzyme 2, mitochondrial (ec 2.7.4.3) (atp-amp transphosphorylase). [source:swissprot;acc:p54819]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2385\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3716.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3569.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04111\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylate kinase isoenzyme 4, mitochondrial (ec 2.7.4.3) (atp-amp transphosphorylase). [source:swissprot;acc:p27144]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2228\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3650.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3484.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04759\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylosuccinate lyase (ec 4.3.2.2) (adenylosuccinase) (asl) (asase). [source:swissprot;acc:p30566]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1640\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7444.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06981\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
679\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6503.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7282.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11992\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
680\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6503.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7282.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11986\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylyl cyclase-associated protein 1 (cap 1). [source:swissprot;acc:q01518]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1541\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5989.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6427.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07311\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adenylyl cyclase-associated protein 2 (cap 2). [source:swissprot;acc:p40123]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1562\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5984.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6419.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07255\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adhesion regulating molecule 1 precursor (110 kda cell membrane glycoprotein) (gp110). [source:swissprot;acc:q16186]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1884\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5826\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6195.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06342\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adipocyte plasma membrane-associated protein (bscv protein). [source:swissprot;acc:q9hdc9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2723\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adiponectin receptor 2. [source:refseq;acc:nm\_024551]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
317\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3153.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3762.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1119\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1118\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1117\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor 1. [source:swissprot;acc:p32889]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor 3. [source:swissprot;acc:p16587]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1826\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor 4. [source:swissprot;acc:p18085]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1819\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase activating protein 1 (adp-ribosylation factor 1 gtpase activating protein) (arf1 gap) (arf1-directed gtpase- activating protein) (gap protein). [source:swissprot;acc:q8n6t3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
982\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase-activating protein 3 (arf gap 3). [source:swissprot;acc:q9np61]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1830\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 1. [source:swissprot;acc:p40616]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1619\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6035.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6464.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07106\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 3. [source:swissprot;acc:p36405]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1534\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5916.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6350.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07344\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 4. [source:swissprot;acc:p40617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
883\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5912.84\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6517.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10229\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
881\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
548\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8268.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9405.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13759\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
af-6 protein. [source:swissprot;acc:p55196]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2076\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5746.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6067.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
afg3-like protein 2 (ec 3.4.24.-) (paraplegin-like protein). [source:swissprot;acc:q9y4w6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1543\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5865.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 1 (ec 1.-.-.-) (afb1-ar 1) (aldoketoreductase 7). [source:swissprot;acc:o43488]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1141\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6303.93\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 2 (ec 1.-.-.-) (afb1-ar 2). [source:swissprot;acc:o95154]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1131\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ah receptor-interacting protein (aip) (immunophilin homolog ara9) (hbv-x associated protein 2). [source:swissprot;acc:o00170]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1904\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5204.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5530.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06261\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [source:swissprot;acc:p24298]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2415\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6956.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7223.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0383\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alanine aminotransferase 2; glutamic-pyruvate transaminase 2. [source:refseq;acc:nm\_133443]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2414\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6956.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7223.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03836\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alanyl-trna synthetase (ec 6.1.1.7) (alanine--trna ligase) (alars). [source:swissprot;acc:p49588]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2599\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4367.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4438.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01627\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alcohol dehydrogenase class iii chi chain (ec 1.1.1.1) (glutathione- dependent formaldehyde dehydrogenase) (ec 1.2.1.1) (fdh). [source:swissprot;acc:p11766]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2249\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6834.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7153.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04677\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
aldehyde dehydrogenase 7 (ec 1.2.1.5). [source:swissprot;acc:p43353]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3222\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
aldehyde dehydrogenase 8 (ec 1.2.1.5). [source:swissprot;acc:p48448]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2992\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
aldehyde oxidase (ec 1.2.3.1). [source:swissprot;acc:q06278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2960\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha adducin (erythrocyte adducin alpha subunit). [source:swissprot;acc:p35611]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1369\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5786.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6241.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha crystallin a chain. [source:swissprot;acc:p02489]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2875\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
alpha crystallin b chain (alpha(b)-crystallin) (rosenthal fiber component). [source:swissprot;acc:p02511]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3082\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha crystallin c chain (small stress protein-like protein hsp22) (e2ig1) (protein kinase h11). [source:swissprot;acc:q9ujy1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2340\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5607.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5855.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (non- neural enolase) (nne) (enolase 1) (phosphopyruvate hydratase). [source:swissprot;acc:p06733]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
945\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-(1,6)-fucosyltransferase (ec 2.4.1.68) (glycoprotein 6-alpha-l- fucosyltransferase) (gdp-fucose--glycoprotein fucosyltransferase) (gdp-l-fuc:n-acetyl-beta-d-glucosaminide alpha1,6-fucosyltransferase) (alpha1-6fuct) (fucosyltransferase 8). [source:swissprot;acc:q9byc5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1544\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5865.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-1-acid glycoprotein 2 precursor (agp 2) (orosomucoid 2) (omd 2). [source:swissprot;acc:p19652]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2254\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7383.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7727.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04663\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-1-syntrophin (59 kda dystrophin-associated protein a1, acidic component 1) (pro-tgf-alpha cytoplasmic domain-interacting protein 1) (tacip1) (syntrophin 1). [source:swissprot;acc:q13424]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1772\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5829.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6218.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06667\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-actinin 1 (alpha-actinin cytoskeletal isoform) (non-muscle alpha-actinin 1) (f-actin cross linking protein). [source:swissprot;acc:p12814]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1345\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-actinin 2 (alpha actinin skeletal muscle isoform 2) (f-actin cross linking protein). [source:swissprot;acc:p35609]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1341\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-actinin 4 (non-muscle alpha-actinin 4) (f-actin cross linking protein). [source:swissprot;acc:o43707]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1346\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07924\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-centractin (centractin) (centrosome-associated actin homolog) (actin-rpv) (arp1). [source:swissprot;acc:p42024]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1151\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5322.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5793.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08838\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-fetoprotein enhancer binding protein (at motif-binding factor) (at-binding transcription factor 1). [source:swissprot;acc:q15911]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2749\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7776.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7783.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00084\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
704\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6912.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7734.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11898\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/